مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

315
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

107
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A COMPARISON BETWEEN PEGYLATED INTERFERON ALPHA-2A AND STANDARD INTERFERON IN COMBINATION WITH RIBAVIRIN IN TREATING PATIENTS WITH BLEEDING DISORDERS AND CHRONIC HEPATITIS C

Pages

  108-115

Abstract

 Background Patients with bleeding disorders are frequently infected with HEPATITIS C virus (HCV). There are few reports on the effect of standard interferon in these patients and no published report on pegylated interferon. The aim of this study was to compare pegylated interferon alpha-2a and standard interferon alpha with ribavirin in patients with bleeding disorders and chronic HCV infection. Materials and Methods Consecutive patients referring to a specialized clinic in Tehran were included in the study. The first 37 patients received pegylated interferon (PEGASYS, Hoffmann-La Roche Inc., Basel, Switzerland), 180 μg weekly and the next 38 patients received standard interferon, 3 million units 3 times a week. Both groups also received ribavirin 800 mg daily. Patients were treated for 48 weeks and were followed for 24 weeks. Liver biopsy was not performed due to the potential risks involved in patients with bleeding disorders. Results 34 patients in each group completed the study. The intention-to-treat sustained viral response was 34% and 62% in the standard interferon and pegylated interferon group, respectively (p=0.02). Conclusions Pegylated interferon alpha-2a and ribavirin is almost twice as effective as standard interferon and ribavirin in treating HCV infection in patients with bleeding disorders and is an acceptable treatment option even when histologic data is not available.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MERAT, SH., SOHRABPOUR, A.A., KHALEGHI, S., SOHRABI, M.R., SAMIMIRAD, K., RADMARD, A.R., MOUSAVIAN, A., KEYVANI, H., & REZVAN, H.. (2005). A COMPARISON BETWEEN PEGYLATED INTERFERON ALPHA-2A AND STANDARD INTERFERON IN COMBINATION WITH RIBAVIRIN IN TREATING PATIENTS WITH BLEEDING DISORDERS AND CHRONIC HEPATITIS C. GOVARESH JOURNAL, 10(2), 108-115. SID. https://sid.ir/paper/532166/en

    Vancouver: Copy

    MERAT SH., SOHRABPOUR A.A., KHALEGHI S., SOHRABI M.R., SAMIMIRAD K., RADMARD A.R., MOUSAVIAN A., KEYVANI H., REZVAN H.. A COMPARISON BETWEEN PEGYLATED INTERFERON ALPHA-2A AND STANDARD INTERFERON IN COMBINATION WITH RIBAVIRIN IN TREATING PATIENTS WITH BLEEDING DISORDERS AND CHRONIC HEPATITIS C. GOVARESH JOURNAL[Internet]. 2005;10(2):108-115. Available from: https://sid.ir/paper/532166/en

    IEEE: Copy

    SH. MERAT, A.A. SOHRABPOUR, S. KHALEGHI, M.R. SOHRABI, K. SAMIMIRAD, A.R. RADMARD, A. MOUSAVIAN, H. KEYVANI, and H. REZVAN, “A COMPARISON BETWEEN PEGYLATED INTERFERON ALPHA-2A AND STANDARD INTERFERON IN COMBINATION WITH RIBAVIRIN IN TREATING PATIENTS WITH BLEEDING DISORDERS AND CHRONIC HEPATITIS C,” GOVARESH JOURNAL, vol. 10, no. 2, pp. 108–115, 2005, [Online]. Available: https://sid.ir/paper/532166/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button